Stay updated on Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Show glossary and Hide glossary UI options were added, and new metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) were introduced. The corresponding older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) were removed or updated.
    Difference
    0.3%
    Check dated 2026-01-22T18:25:08.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no study content or functionality changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T12:55:21.000Z thumbnail image
  4. Check
    49 days ago
    Change Detected
    Summary
    Added Beijing Municipality under Locations and updated the location labeling; added Snyder et al. 2014 NEJM citation to Publications, while removing the previous Beijing Municipality Locations entry and its related Erratum citation.
    Difference
    0.3%
    Check dated 2025-12-17T21:59:57.000Z thumbnail image
  5. Check
    70 days ago
    Change Detected
    Summary
    Publications section updated to clarify that publications are provided voluntarily by contributors who enter information about the study results, and the site revision badges were updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-26T13:47:37.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Publications section updated: a 2014 NEJM paper on CTLA-4 blockade was added with erratum details, and the previous citation entry was removed.
    Difference
    0.4%
    Check dated 2025-11-19T08:17:42.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    The two screenshots show the same Study Details page with identical trial information (title, conditions, eligibility criteria, interventions, outcomes, and locations). No core content or data elements were added or removed.
    Difference
    0.4%
    Check dated 2025-10-28T05:18:54.000Z thumbnail image

Stay in the know with updates to Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.